Skip to Content
Merck
CN

541397

10-Bromodecanoic acid

95%

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
Br(CH2)9CO2H
CAS Number:
Molecular Weight:
251.16
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
MDL number:
Assay:
95%
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Level

assay

95%

reaction suitability

reagent type: linker

mp

38-41 °C (lit.)

functional group

carboxylic acid, bromo

SMILES string

OC(CCCCCCCCCBr)=O

InChI

1S/C10H19BrO2/c11-9-7-5-3-1-2-4-6-8-10(12)13/h1-9H2,(H,12,13)

InChI key

PGVRSPIEZYGOAD-UHFFFAOYSA-N

General description

10-Bromodecanoic acid can be prepared from 10-bromodecanol via oxidation.

Application

10-Bromodecanoic acid may be employed as an alkylcarboxylate chain source in the preparation of alkylcarboxylate-grafted polyethylenimine. It may also be used in the synthesis of :
  • 10-(methylsulfinyl)decanoic acid
  • 10-cyanodecanoic acid
  • (10-oxo-10-(4-(3-thioxo-3H-1,2-dithiol-5-yl)phenoxy)-decyl)triphenylphosphonium bromide
  • 11-thiastearic acid


Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Sara Ayatollahi et al.
The international journal of biochemistry & cell biology, 92, 210-217 (2017-10-17)
RNAi-based gene therapy has been recently considered as a promising approach against cancer. Targeted delivery of drug, gene or therapeutic RNAi-based systems to tumor cells is one of the important issues in order to reduce side effects on normal cells.
M D Rahman et al.
Journal of medicinal chemistry, 31(8), 1656-1659 (1988-08-01)
A variety of analogues of stearic acid in which one of the methylene groups was replaced by a sulfur atom were examined as inhibitors of growth and fatty acid biosynthesis in the trypanosomatid protozoan Crithidia fasciculata. The 8-, 9-, 10-
The synthesis and functional evaluation of a mitochondria-targeted hydrogen sulfide donor,(10-oxo-10-(4-(3-thioxo-3 h-1, 2-dithiol-5-yl) phenoxy) decyl) triphenylphosphonium bromide (Ap39).
Le Trionnaire S, et al.
MedChemComm, 5(6), 728-736 (2014)



Global Trade Item Number

SKUGTIN
541397-5G04061831811148
541397-25G04061831830323